Kalamazoo, Michigan-based Stryker Corporation has appointed Robbie Robinson president of its Spine division.
Robbie Robinson Stryker Spine’s New President “Let’s Go!”
A 17-year veteran of the medical technology industry, Robinson has had a long and storied career with Stryker, beginning in 2004 when he joined the team in the Endoscopy division.
“We are excited to welcome Robbie Robinson, incoming President of Stryker’s Spine division, to our team,” said Stryker in their press announcement, “With over 17 years of experience and success at Stryker across Interventional Spine, Endoscopy, and Orthopaedic Instruments, Robbie is committed to delivering meaningful innovations to our customers.”
Robinson’s experience in a variety of Stryker’s product sectors and with increasing levels of responsibility has prepared him to manage one of spine’s premier suppliers—Stryker Spine. Specifically, Robinson has worked in nearly every major Stryker functional group including research and development, finance, medical education, and legal and compliance.
Most recently, Robinson served as vice president and general manager of the Orthopaedic Instruments division. Prior to that role, he served as vice president and general manager of the Interventional Spine business.
A Stryker spokesperson told OTW that Robinson has “consistently delivered exceptional results in sales, marketing, and leadership roles of increasing scope and complexity.”
The spokesperson continued, “He [Robinson] is known for driving high-performing cultures, building inclusive teams, and leveraging a customer-focused mindset.”
In his new role, Robinson will bring his understanding of how to lead and engage teams as well as his extensive knowledge of Stryker’s business.
Robinson, in accepting his new post, reached back to acknowledge the leader who previously led Stryker Spine—Eric Major, founder of K2M. “It’s official! I’m honored and humbled for this amazing opportunity to lead Stryker Spine! I’d like to extend a huge thank you to Eric Major for his work, dedication and leadership of this great organization.”
Robinson continued, “As we begin this next chapter, Spine will charge forward with a commitment to our mission, our values, our customers and our people and we’ll work hard to make healthcare better, together. Let’s go!”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.